08:00 , Nov 19, 2015 |  BC Innovations  |  Product R&D

Bugs against chlamydia

Synthetic biology company Prokarium Ltd. is creating oral vaccines based on a bacterial system that produces a wider range of antigens and fewer side effects than injectables. With its goal to produce the first vaccine...
08:00 , Dec 20, 2010 |  BioCentury  |  Emerging Company Profile

BigDNA: Fewer Shots on Goal

Most marketed HBV vaccines, as well as DNA vaccines in development for the disease, require multiple booster injections or an adjuvant to trigger an immune response. BigDNA Ltd. believes its bacteriophage-delivered DNA vaccine will require...